Karla Mišura-Jakobac

3PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 12, 2025
Biomarkers Affecting Treatment Outcomes of Febrile Neutropenia in Hematological Patients with Lymphomas: Is Presepsin the New Promising Diagnostic and Prognostic Biomarker?

Karla Mišura Jakobac, Vibor Milunović, Vesna Kušec

|Jan 08, 2025
Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases.

Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda

|Nov 27, 2024
Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM).

Josip Batinić, Barbara Dreta, Goran Rinčić

Pageof 1

Frequent Collaborators

2 joint publications

Vibor Milunović

1 joint publications

Antonia Mrdeža

1 joint publications

Milan Vujčić

1 joint publications

Ivan Krečak